Monitor for first commercial helium shipments from Renergen by end of September 2026, which would validate the operational timeline. The merger with ENDRA remains on track; watch for the S-4 proxy statement filing for deal specifics and shareholder vote timing.
Price Chart
Executive Summary
ASP Isotopes filed a Rule 425 communication containing a transcript from its inaugural Capital Markets Day in London on September 8, 2026. Management confirmed that the Renergen helium plant has reached the target temperature of 4 Kelvin and expects first commercial production by the end of September 2026. CEO Paul Mann stated that post-merger, ASP Isotopes will own 89% of the listed Noble Africa (Renergen) entity, with a 10-11% free float, and reiterated the 2031 revenue target of $300 million (range $30M-$700M) with Renergen expected to achieve 80%+ gross margins at that scale. The filing is a promotional update within the active M&A process (reverse merger with ENDRA Life Sciences) but contains no new financial data or changes to deal terms.
Key Financial Metrics
Key Facts
- Renergen's Virginia Gas Project plant hit target temperature of 4 Kelvin and should start commercial production by end of September 2026.
- ASP Isotopes will own 89% of Noble Africa (Renergen) post-reverse merger with ENDRA, with 10-11% free float.
- 2031 revenue target of $300 million (range $30M-$700M) reiterated; Renergen expected to have 80%+ gross margins at that scale.
- No changes to merger terms or new financial data disclosed in this filing.
Financial Impact
No new financial data; 2031 revenue target of $300M reiterated with Renergen 80%+ gross margin assumption at scale.
Risk Factors
- Renergen Phase 1 commissioning delays beyond September 2026.
- Failure to obtain ENDRA stockholder approval for the reverse merger.
- Inability to secure debt funding for Phase 2 of the Virginia Gas Project.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001477932-26-005473 |
| Document: 0001477932-26-005473-index-headers.html | 0001477932-26-005473 |
| Document: 0001477932-26-005473-index.html | 0001477932-26-005473 |
| Document: 0001477932-26-005473.txt | 0001477932-26-005473 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $2.07 | awaiting T+5 | — | $2.03 (−2.18%) |
Oct 15, 2026 11d ago | 8-K | $2.21 $2.09 | ▼ −5.43% | ▼ −4.42% | $2.03 (−8.34%) |
Oct 2, 2026 24d ago | 8-K | $2.91 $2.65 | ▼ −8.93% | ▼ −10.10% | $2.03 (−30.39%) |
Sep 25, 2026 4w ago | 144 | $2.60 $2.93 | ▲ +12.69% | ▲ +11.49% | $2.03 (−22.09%) |
Sep 9, 2026 6w ago | 425 | $3.82 $3.15 | ▼ −17.54% | ▼ −16.44% | $2.03 (−46.97%) |
Sep 2, 2026 7w ago | 144 | $3.90 $3.31 | ▼ −15.13% | ▼ −13.98% | $2.03 (−48.06%) |
Aug 20, 2026 9w ago | 425 / 8-K | $3.95 $4.04 | ▲ +2.41% | ▲ +1.29% | $2.03 (−48.65%) |
Aug 18, 2026 9w ago | 8-K | $3.86 $4.00 | ▲ +3.63% | ▲ +3.83% | $2.03 (−47.52%) |
Aug 16, 2026 10w ago | Institutional Cluster | $4.02 $3.89 | ▼ −3.23% | ▼ −2.04% | $2.03 (−49.61%) |
Aug 5, 2026 11w ago | 425 | $4.10 $4.28 | ▲ +4.39% | ▲ +3.18% | $2.03 (−50.60%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers